SN Comprehensive Clinical Medicine

, Volume 1, Issue 1, pp 49–59 | Cite as

Diabetes and Sperm DNA Damage: Efficacy of Antioxidants

  • Nagarajan Laleethambika
  • Venugopal Anila
  • Chandran ManojkumarEmail author
  • Ishvarya Muruganandam
  • Bupesh Giridharan
  • Thangarasu Ravimanickam
  • Vellingiri BalachandarEmail author
Part of the following topical collections:
  1. Topical Collection on Medicine


Diabetes mellitus (DM) represents one of the major threats to human health all over the world, affecting almost every system of the body. Its prevalence is escalating globally and is associated with reproductive impairment in both males and females. Reports on male infertility due to DM is lacking since most affected individuals are unaware of their infertility condition due to the late onset of DM. Glucose metabolism is an imperative occasion in spermatogenesis, causing adverse effects on male fertility, principally on sperm DNA quality, motility, and ingredients of seminal plasma. DM is coupled with an increased oxidative stress (OS), causing sperm nuclear and mitochondrial DNA damage. Reactive oxygen species (ROS) hassles the fluidity of sperm plasma membrane, decreases sperm motility and ability to fuse with oocyte as well as altering the sperm DNA integrity. Lamentably, spermatozoa cannot repair the damage initiated by excessive ROS as they do not have the cytoplasmic enzymes required to achieve the repair. Diabetes may impact the epigenetic change during spermatogenesis which may be inherited through male gamete to more than one generation increasing the risk of diabetes in offspring. Administration of antioxidants in male infertility has started to pull in significant intrigue. Many studies have shown that antioxidants amazingly reduce the oxidative stress markers and boost the antioxidant enzymes. Currently treatment strategies are aimed at lowering ROS levels to maintain normal cell function. This review highlights the potential impact of DM on sperm DNA integrity, epigenetic dysregulation and efficacy of antioxidant therapy.


Antioxidants Diabetes mellitus Epigenetic dysregulation Oxidative stress Sperm DNA integrity 


Diabetes mellitus (DM), characterized by chronic hyperglycemia is a metabolic disorder of numerous etiologies, causing disturbance in carbohydrate, fat, and protein metabolism due to defects in insulin secretion and insulin action or both [1]. The DM could provoke long-standing dysfunctions, damages, and failures of numerous organs. Many reviews in both human and animals have affirmed the malicious impact of diabetes on sexual functions for example, semen parameters, sperm DNA integrity, and chromatin quality [2, 3, 4]. Worldwide rates of male infertility extend from 2.5 to 12% implying that 30 million men globally are infertile. Even though oxygen is imperative for aerobic metabolism of spermatogonia, it may have adverse effects on cells through generation of ROS [5]. ROS are free radicals that assume a noteworthy part in a significant number of the sperm physiology, namely, capacitation, hyperactivation, and sperm-oocyte fusion [6, 7, 8]. Studies have shown that DNA integrity of spermatozoa is essential for normal fertilization and inheritance of paternal gene in offspring [9, 10]. As spermatozoa lack cytoplasmic defenses, they are sensitive to oxidative stress (OS) [11, 12]. In addition, the sperm plasma membrane has lipids as polyunsaturated fatty acids, which are susceptible to assault by ROS resulting in lipid peroxidation [13, 14, 15]. Epigenetic modifications such as DNA methylation, remodeling of nucleosomes, histone modifications, and non-coding RNAs and higher-order chromatin reorganization are essential during spermatogenesis. Environmentally induced epigenetic modifications during embryonic gonadal development and germline differentiation might become stable in epigenome of germline leading to epigenetic transgenerational inheritance. In this paper, we first illustrate the role of glucose metabolism and oxidative stress in spermatogenesis and the impact of diabetes on male fertility. We enumerate the epigenetic dysregulation and unique features of sperm DNA integrity. In addition, the rationale for antioxidant therapy will be critically reviewed.

Chromatin Structure of Human Spermatozoa

Figure 1 illustrates the typical structure of a human spermatozoa. Human sperm chromatin has three major structural domains, majority of them are bound to protamines and coiled into toroids [16], small fraction is bound to histones [17, 18, 19, 20, 21], and sperm DNA is attached at interval of roughly about 50 kb to sperm nuclear matrix throughout the entire genome [22, 23]. Toroid linker, a nuclease sensitive segment of chromatin located in between each protamine toroid, is another site for connection of DNA to nuclear matrix. The actual size of these linkers is not predicted but expected to be within 1000 bp, about 2% of toroid size [24]. Initial expression of nuclear packaging proteins, protamines, and transition proteins occurs during spermiogenesis, a haploid stage of spermatogenesis [25]. Protamines contain some cysteines forming intermolecular disulfide cross-links which increases during their transport in epididymis and providing increased stability to sperm chromatin. In vitro, reducing reagents are used to decondense DNA of sperm cell [26, 27, 28]. A major function of the sperm chromatin is restricted for fertilization excluding embryonic development. During spermiogenesis, gene expressions are silenced by protamine binding [23, 29, 30]; beyond fertilization, protamines acts as a protectant. Kuretake et al. demonstrated the shielding effect provided to chromatin of spermatozoa by protamine binding, in an experiment conducted using mouse sperm which was sonicated for a short time before injecting into oocytes [31].
Fig. 1

Structure of human spermatozoa

Diabetes Mellitus and Male Infertility

The incidence of DM is increasing worldwide leading to impairment in reproductive function in both sexes. DM influence male reproduction at various stages by affecting the endocrine control of spermatogenesis and sperm maturation and by causing impairment in penile erection and ejaculation. It has been claimed that the common causes of infertility among diabetics are ejaculatory dysfunction (retrograde and antegrade) and endocrine control. Reports on men with DM and infertility are limited and not well studied. A major reason to this could be due to the age factor. In most cases, men with infertility issues due to DM are not identified since DM usually develops during the later stages of life [32, 33]. A study conducted by Loghmani demonstrates that prolonged rise in blood sugar levels is linked with micro- and macrovascular complications resulting in heart diseases, kidney diseases, blindness, and stroke. Strikingly, diabetic men who exhibited typical semen parameters indicated fundamentally more elevated amounts of defect in sperm mitochondrial and nuclear DNA, presumably coming about because of supra-physiological glucose levels and associated oxidative anxiety [3]. Apart from hyperglycemia, various other factors also play a vital role in pathology of DM, namely, oxidative stress and hyperlipidemia ending in major risk of complications [34]. In addition, advanced glycation end product’s (AGEs) resulting from oxidative damage have been identified in elevated levels in seminal plasma, reproductive tract and sperm of diabetic males suggesting their role in ROS induced damage in sperm DNA [35, 36, 37]. In many circumstances, chromosomal disorders contribute to the underlying cause of reproductive outcome [38]. A study conducted by a group of authors narrated the sequestered and uninterrupted effect of elevated glucose levels on male gamete by incubating spermatozoa for 2 days supplemented with PBS-medium mimicking in vivo conditions [39, 40, 41].

Glucose Metabolism in Sperm

Except few metabolites like citrate and lactate, sperm principally consume sugars as vitality source including glucose, fructose, and mannose. Oxidative phosphorylation and anaerobic glycolysis are the two primary metabolic pathways required in energy production [42]. As reported in earlier findings, male reproductive well-being depends primarily on glucose intake and metabolism by testicular cells. Polar molecules like glucides rich in –OH groups gets transported across the lipidic bilayer in a passive and inactive manner. Therefore, carriers are essential for their utilization by cells [43]. Two family of membrane proteins transport glucose across the blood-testis barrier, namely, sodium-dependent glucose transporters (SGLT) or glucose transporters (GLUT) that can actively and passively transport hexoses across the lipidic bilayer [44, 42]. Different GLUTs in sperms has the adaptability to adjust to variations in the environment, metabolic prerequisites, and so on. Conversely, an unfavorable situation like diabetes can bring about dysfunction in nutrient exchange, therefore prompting reduced fertility and poor pregnancy outcomes [45, 46].

Oxidative Stress in Diabetes Mellitus

Sperm glucose take-up and metabolism are basic for male fertilizing capacity. Sperm cells utilizes few substrates for energy requirements, hence the dysregulation in glucose take-up and metabolism in hyperglycemia may produce negative effect on sperm quality [47]. Oxidative stress induced by hyperglycemia is currently perceived as the main impetus for the advancement of diabetic complications [48]. A study conducted by Ayepola has identified that free radicals play a vital role during the onset and progression of late diabetic complication, as they have the capacity to damage proteins, lipids, and DNA [49]. In DM, in addition to oxidative stress, insulin dysfunction and glucose availability may lead to severe alterations in testicular cells, along with mitochondrial and nuclear DNA fragmentation. Studies have shown that oxidative stress developed during sperm metabolism affects the sperm function [50, 51]. Cells undergo apoptosis or necrosis in an oxidative environment and is the main pathway leading to sperm DNA breaks in sperm. Apoptosis and necrosis are likely triggered by an impairment of chromatin maturation in the testis during the transit in the male genital tract and occurs during spermatogenesis or after spermiation or both. These are relevant for the development of new drugs to rectify sperm DNA fragmentation (sDF) and OS in infertile men [52]. Hyperglycemia produces more ROS, as well as diminishes antioxidative mechanism by hunting enzymes and substances [53]. Lactate is fundamental for germ cells as it is by all accounts a dynamic metabolite that serves as energy for their advancement [54]. Past clinical and exploratory reviews proposed that DM modifies glucose take-up from Sertoli cells and its oxidation to pyruvate and lactate [55, 56]. The disruption of its synthesis could lead to abnormal seminal parameters such as concentration, motility, viability, and morphology. It is trusted that oxidative stress assumes critical part in the progress of vascular complications especially in type 2 diabetes [57]. Variation in the levels of enzymes superoxide dismutase (SOD), catalase (CAT-enzymatic/non-enzymatic), and glutathione peroxidase (GSH–Px) makes the tissues vulnerable to oxidative insult resulting in the development of vascular complications [58]. Here, oxidative stress brings about incitement of polyol pathway, development of advanced glycation end products (AGE), enactment of protein kinase C (PKC), and ensuing materialization of reactive oxygen radicals [59, 60]. Mitochondria is the chief source of oxidative stress in diabetes. In mitochondria during oxidative metabolism, a part of the consumed oxygen is condensed to water and the residual oxygen is converted into oxygen free radical (O) which is an essential ROS that is changed over to different reactive species, namely, ONOO, OH, and H2O2 [61].

Reactive Oxygen Species in Semen

Oxidative stress (OS) is a state related with an increased cellular damage induced by oxygen and their derived oxidants, namely, ROS [62]. Under normal conditions, spermatozoa are capable of producing ROS and it is the ROS that helps in the penetration of spermatozoa into the oocyte through the zona pellucida. During abnormal conditions (atypical sperms), ROS is produced in excess causing an imbalance in the level of antioxidants leading to oxidative stress [63, 64]. ROS provoke harm to cells by transient unpaired electron ensuing oxidation of molecules and cell components [65]. Further, it also reflects the inequity between ROS and the body’s ability to actively detoxify the end products of OS or to repair the damages produced by it [66, 67]. Cells undergo apoptosis or necrosis in oxidative environment, on the other hand reducing environment leads to cell survival [68]. Both intrinsic and extrinsic sources of ROS exist in semen. Intrinsic sources are activated leukocytes due to infection and inflammation [69, 70, 71, 72], immature spermatozoa with abnormal morphology and cytoplasmic retention [73], and abnormal and defective spermatozoa due to compromised spermatogenesis [74, 75]. Hipler et al. have demonstrated that even Sertoli cells in semen have the capacity to produce ROS [76]. Various other intrinsic causes are aging, varicocele, testicular torsion, and cryptorchidism [77, 78]. Extrinsic sources associated with increased seminal and/or testicular ROS levels are alcohol consumption [66], environmental toxins [78], cigarette smoking [79], and exposure to radiation [80, 81]. A wide range of air pollutants, such as O3, NO2, and particles, also can produce an excessive production of ROS. They resulted in damage to DNA, lipids, and proteins, altering enzymatic systems and cell apoptosis and, ultimately it also led to decreasing semen quality [73]. This study finds a robust association between exposure to air pollution and a low percentage of sperm normal morphology in reproductive-age men [82].

Sperm DNA Damage

Over the previous decade, there has been a developing collection of research exploring the part of sperm DNA integrity in male infertility. Physical and chemical environmental change may influence reproductive function [83]. In our atmosphere, we are constantly exposed to minimal doses of ionizing radiation [84]. Study conducted by Balachandar et al. discussed about the adverse effect of ionizing radiations leading to stable and unstable alterations in chromosome and in turn may probably lead to DNA damage [85]. Sperm chromatin damage is also found in 8% of males with normal semen parameters [86]. It has been proposed that sperm DNA integrity might be a superior indicator of male fertility than routine semen investigation. Sperm DNA damage has been related to elevated amounts of ROS [87]. Elevated levels of defective sperm DNA are often associated with poor seminal factors like decreased count, movement, or abnormal forms [88, 89, 90]. There is confirmation that sperm of infertile men encompass more DNA impairment than fertile men, and this defect may negatively affect fertilizing capability of these patients [91]. At minimal quantity, ROS assume a vital part in sperm development and roles, like acrosome reaction and capacitation [92]. Sperm chromatin has a very consolidated and sorted out structure that shields it from oxidative insult [93]. However, when compactness is reduced and chromatin protamination is deficient, sperm DNA is more susceptible to ROS. As examined already, in the course of spermiogenesis, sperm chromatin experiences a critical stride in restructuring in which histones are supplanted by protamines. This chromatin rebuilding is enabled by the synchronized slackening of chromatin structures by histone hyper-acetylation and in addition the compound DNA topoisomerase II (topo II) which produces brief scratches in the sperm DNA to release torsional strain subsequent to supercoiling [94, 95, 96]. Moreover, these transitory scratches are then regularly repaired by this same compound, before completion of spermiogenesis and discharge. If these nicks are not mended, spermatozoa with fragmented DNA might be available in the ejaculate [97].

Plasma of seminal fluid contains antioxidants which secure sperm DNA [98]. When an over the top measure of ROS is created past the antioxidant limit of male reproductive tract and seminal plasma, the pathogenic outcome is habitually DNA and cellular damage [92]. DNA damage triggers apoptosis [99], and in instances of more serious defect of spermatozoa, apoptosis brings about decreased sperm count distinctive of idiopathic male factor infertility [100]. ROS influences nuclear or mitochondrial DNA of sperm at an amino acid or sub-atomic level, by base change (particularly guanine), assaulting the phosphodiester backbones and generating base free sites, deletions, point mutations, frame shifts, polymorphisms, strand breaks, rearranging chromosomes, translocations, and chromatin cross-links [100, 101, 102]. Defective sperm DNA may decline fertilizing capacity, increase pregnancy wastages and tendency for congenital anomalies, decrease the implantation, and finally weakens embryonic development [103, 104]. An additional hypothesis of sperm DNA defect is through failed apoptosis. Generally, apoptosis occurs in testicles to inhibit increased generation of germ cells and to specifically obliterate harmed germ cells [105]. Sertoli cells boost a set number of germ cells in the testis. Clonal extension of germ cells is in abundance, and along these lines apoptosis is important to restrain the measure of the germ cell populace to one which Sertoli cells can bolster [106]. Increase in the sexual abstinence period influences sperm quality. This indicates an important correlation between the duration of ejaculatory abstinence and semen parameter variation. It highlights the deleterious effect of increased abstinence on DNA damage, which is most likely associated with ROS [107].

Another study which provides solid evidence for vascular endothelial growth factor (VEGF) becoming a therapeutic target in type 2 diabetes mellitus (T2DM) related male infertility. It demonstrates that T2DM can reduce testicular VEGF expression, which results in testicular microcirculation impairment, and then induces testicular morphological disarrangement and functional disorder. These actions are triggered by PI3K/Akt pathway. The decrease of testicular VEGF is related to the testicular cells apoptosis, damage of rat Sertoli cells, and inactivation of PI3K/Akt pathway triggered by long-term hyperglycemia. Here they strongly believe, that the VEGF as a good therapeutic target for T2DM induced male infertility. These indicated that VEGF had a protective effect on hyperglycemia-induced sperms damage in DNA level [108].

Impact of Epigenetic Regulation in Spermatogenesis and Male Infertility

During spermatogenesis, epigenetic mechanisms acts as critical regulators for gene expression, which in turn have control on male reproductive function [109, 110, 111]. In male reproductive function, epigenetic regulation plays a major role by controlling germ cell growth and maintenance [111, 112, 113, 114, 115]. DNA methylation is a kind of epigenetic alteration that can efficiently endorse gene silencing. Development of germ cell is a well-organized process originating during the fetal growth and ending in adult stage. Therefore, epigenetic changes happening in gametes are vital for function of gametes and for embryonic growth after fertilization [116]. Gonocytes are the only germ cells found in prenatal testis which undergo proliferation for a short period and then decline. These gonocytes turn out to be spermatogonia, as they reach the basement membrane after birth and then recommences proliferation. They undergo mitotic cell division—and constitute the group of stem cells, giving way for meiosis and spermatogenesis. Preceding spermatogenesis, gonocytes and spermatogonia transposable elements (TEs) are silenced [117]. A study has revealed that there exists a considerable difference in epigenomes of somatic cells and sperm cells through genome-wide methylation studies. Further they identified that sperm epigenome is very much related to that of embryonic stem cells [118, 119]. In spermatozoa, the promoters especially of developmental genes are greatly hypomethylated. MEST/PEG1 are paternally expressed human genes, they are demethylated in fetal stage and stay unmethylated during the entire process of spermatogenesis [120]. In this manner, unusual imprinting as an after effect of DNA methylation dysregulation might be connected with male infertility. Moreover, many research studies have reported that altered spermatogenesis is associated with imprinting errors [121]. Men with low sperm count showed the event of intergenic-DMR and hypomethylation of H19 or hypermethylation at a few maternal DMRs, particularly when the sperm concentration is < 10 × 106/ml [122, 123, 124]. Methylation was obviously reduced in men diagnosed with oligoasthenoteratozoospermia at all CpGs, achieving statistical importance especially in patients with count < 10 × 106/ml. Therefore, these discoveries recommend that atypical DNA methylation intervened genomic imprinting is connected with oligozoospermia and oligoasthenoteratozoospermia [125, 126, 127, 128].

Parental Diabetes and Epigenetic Regulation

Gestational diabetes exerts adverse effect on the organization and function of testicular structures and endocrine system of reproductive organs equally. This harmful alteration takes place during early embryonic stage and lasts until postnatal life, which was observed previously by Jelodar et al. in diabetic adult male rats [129]. The methylation enabled by DNA methyltransferase (DNMT) 3 L is responsible for silencing of TEs in testis. Gonocytes express DNMT3L when universal DNA methylation occurs at 14–18 days after fertilization. Experimental study conducted in adult mice has suggested undeniably that the lack of TEs silencing leads to meiotic arrest and infertility in adult mice [130, 131]. Establishment of paternal imprinting of genes occurs approximately about 15.5 days after fertilization in gonocytes and carried out through spermatogonia. In male germ cells, these genes are methylated and subjected to silencing. Factors, namely, BORIS (brother of the regulator of imprinted sites) and the DNMT, DNMT3A, DNMT3B with its closely related DNMT3L, are involved in establishing the paternal imprints in male gametes. Loss of methylation was observed in paternally imprinted regions due to deletion of Dnmt3L. Sperm cells lacking Dnmt3a and Dnmt3b revealed disparities in methylation patterns at paternally imprinted regions [132]. In addition, elevated blood glucose levels in males alters the general methylation patterns in spermatogonia with an expanded portion of differentially methylated genes intersecting with pancreatic islets in fetus implying that paternal prediabetic condition may increase the risk of diabetes in progeny through epigenetic alterations in gametes [133].

Role of Antioxidants

Due to lack of cytoplasmic enzymes, spermatozoa are incapable of restoring oxidative damage. Antioxidants may be a promising supplementary therapy for diabetic male patients to alleviate ejaculatory disorders but alone is not an effective treatment for the mitigation of infertility [134]. Many researchers have identified the significant role of antioxidants in andrology. Antioxidants shield the sperm cells from destructive action of ROS. Three dissimilar antioxidant protection systems, namely, endogenous antioxidants, dietary antioxidants, and metal-binding proteins play a pivotal role in decreasing OS in males [135, 136, 137, 138]. List of antioxidants in semen is given in Table 1. Furthermore, there are two types of antioxidants such as scavenger antioxidants and prevention antioxidants. Metal binding proteins and metal chelators are prevention antioxidants, they block new ROS formation, whereas ROS previously formed are removed by scavenger antioxidants. A study conducted by Biemond et al. and Ochsendorf has demonstrated the involvement of transition metal ions, especially iron in formation of highly reactive –OH by Fentons reaction [139, 140, 141]. In vivo Astaxanthin (ASTX) treatment could partially improve sperm viability, normal morphology, and DNA integrity [142]. In cryopreserved sperm DNA, the addition of leptin to capacitated sperm did not inhibit ROS formation directly but can improve sperm DNA. The activity of certain antioxidant enzymes helps to protect sperm DNA from damage [143].
Table 1

Types of antioxidants in semen

Endogenous antioxidant

Dietary antioxidant

Metal-binding proteins



Superoxide dismutase (SOD)


Vitamin C




Vitamin E


Glutathione peroxidase/

Vitamin E



Glutathione reductase










Vitamin A





Dietary antioxidants constitute the scavenger type of antioxidant. They play vital role in antioxidant defense system of humans. Fruits, vegetables, and dietary supplements act as potential source of numerous antioxidants. Chain-breaking antioxidants like vitamin E and vitamin C can be used to limit oxidative stress [144]. Cochrane meta-analysis on the use of oral antioxidants in male infertility found that these agents significantly improved pregnancy rates and live births and decreased sperm DNA damage [145].

A study found that Trolox protected the Wi-Fi-exposed semen in vitro from the damage of electromagnetic radiation-induced OS. They concluded that 2.45 GHz Wi-Fi could impair human sperm in vitro through the effects of OS on sperm DNA and mitochondria. Trolox could mitigate the harmful effects of 2.45 GHz Wi-Fi electromagnetic radiation by inhibiting OS damage to sperm DNA and mitochondria. They offer supportive evidence for clinical use of Trolox to prevent the adverse effects of Wi-Fi exposure on the male reproductive system [146].

During cryopreservation and post-thaw incubation of sperm, there was a chance of ROS-induced damages to spermatozoa. Addition of cysteine is recommended in rabbit breeding industry to facilitate the improvement of semen preserved. They not only improved semen parameters but also enhanced the parameters during post-thaw incubation and increased motility and integrity of acrosome and plasma membrane during the cooling process. The cysteine enhanced antioxidant glutathione GSH content and the activity of glutathione peroxidase, while lowered ROS and lipid peroxidation (LPO) level, which makes spermatozoa avoid ROS to attack DNA, the plasma membrane, and mitochondria [147]. Studies on many antioxidant agents and Chinese medicinal herbs have been investigated for their role in diminishing ROS activity in the cauda epididymis of male animals, but it fails to provide strong experimental evidence [148]. Mechanism of action and effect of major antioxidants are shown in Table 2. Even though many studies have been done evaluating the role of antioxidants, its positive effects are still under debate. Many researchers have noticed no progress with subsequent antioxidant uptake.
Table 2

Mechanism of action and effect of various antioxidants

Enzymatic antioxidant


Mechanism of action




Glutathione reductase and glutathione peroxidase

Act as scavenging antioxidants in the epididymis and testes

Protects lipid constituents in membrane and improve sperm membrane characteristics

Preserve sperm viability and motility

Mora-Esteves and Shin 2013 [149]

Superoxide dismutase and catalase

Catalyzing the conversion of superoxide into oxygen and H2O

Prevents lipid peroxidation

Improve motility

Agarwal et al. 2004 [136]


Detoxifies both intracellular and extracellular H2O2 to water and oxygen, activates nitrous oxide (NO)-

Prevents lipid peroxidation, induce sperm capacitation

Improve sperm membrane characteristics, improves fertilization

Baker et al. 1996 [150], Lamirade et al. 1997 [151]

Non-enzymatic antioxidant

 Vitamin E

Chain-breaking antioxidant

Neutralize H2O2 Quench free radicals prevents lipid peroxidation

Improve sperm membrane characteristics and activity of other antioxidants

Lampiao 2012 [152], Mora-Esteves and Shin 2013 [149]

 Vitamin C

Chain-breaking antioxidant

Fight OS in the seminal plasma (Upto 65%)

Protects sperm viability and motility

Sharma and Agarwal 1996  [153], Lampiao 2012 [152]


Water soluble dietary antioxidant

Assist free fatty acid utilization, prevent lipid peroxidation

Prevent sperm DNA damage, maintains sperm viability and motility

Mora-Esteves and Shin 2013 [149], Sharma and Agarwal 1996 [153]

Carotenoids Single molecular oxygen quenchers

Sies 1993 [154



Prevents lipid peroxidation in sperm membrane

Improves semen quality

Basnal and Bilaspuri 2011 [155]


Prevents lipid peroxidation in seminal plasma

Improves semen quality

Lampiao 2012 [152]


Precursors of intracellular GSH

Increase amount of GSH synthesis, GSH scavenges oxidants, prevents oxidative damage

Prevents oxidative damage to cell membrane and DNA

Basnal and Bilaspuri 2011 [155]


Competitive phosphodiesterase inhibitor

Prevents breakdown of intracellular camp, suppress synthesis of tumor necrosis factor-α (TNF-α) and leukotrienes

Decreases inflammation, sperm motility preserved

Mora-Esteves and Shin 2013 [149]


Parental nutritional status and metabolism are essential factors for determining the health status of offspring in adult stage. Due to massive increase in metabolic disease like diabetes, there is an alarming necessity to monitor the adverse environmental influence on the germ cells. Decline in fertility rate is observed in male with diabetes either type I or type II. Molecular studies with sperm from diabetics are still scarce since most men are unaware of their condition due to the development of DM due the later stages of life. Most of the mechanisms through which sperm manage to attain their energy metabolism in diabetic men remain to be disclosed. The studies deliberated in this review validate that glucose metabolism is very essential for spermatogenesis. Therefore, there is an urgent need for more studies focused on the molecular mechanisms beyond glucose transport in sperm of diabetic men. Diabetes could ensure detrimental effects on sperm motility, sperm quality, sperm DNA integrity, and seminal plasma ingredients. In a healthy condition, there exists a balance between ROS generation and antioxidant activity in male reproductive system. In diabetes, due to excess production of ROS in semen, sperm, and seminal plasma antioxidant, defense mechanism is affected which leads to oxidative stress. However, there is a more profound lack of literature concerning the effect of DM in the functioning of testicular cells. In addition, diabetes may produce alterations in epigenetic modifications during spermatogenesis, these changes might be carried over through male gamete and transmitted to many generations, resulting in increased risk of diabetes in progeny. Studies explaining the mechanism behind epigenetic regulation of DNA methylation during spermatogenesis are still in preliminary stage. There also seems to be an association between DNA methylation and male infertility. In the future, the research should be focused to identify the molecular mechanism underlying the potential impact of diabetes on epigenetic dysregulation during spermatogenesis, and its transgenerational inheritance. Many studies states that antioxidant therapy may improve sperm quality and in turn male fertility. Further studies should be done to ascertain the effectiveness of antioxidants to nullify the effects of ROS, and to prevent the oxidative damage.



The authors would like to thank all the research scholars in our lab for providing support to complete this review.

Compliance with Ethical Standards

Competing Interests

The authors declare that they have no competing interests.


  1. 1.
    Alberti KGMM, Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.PubMedGoogle Scholar
  2. 2.
    Cavallini G. Male idiopathic oligoasthenoteratozoospermia. Asian J Androl. 2006;8:143–57.PubMedGoogle Scholar
  3. 3.
    Agbaje I, Rogers D, McVicar C, McClure N, Atkinson A, Mallidis C, et al. Insulin dependant diabetes mellitus: implications for male reproductive function. Hum Reprod. 2007;22:1871–7.PubMedGoogle Scholar
  4. 4.
    Kilarkaje N, Al-Hussaini H, Al-Bader MM. Diabetes-induced DNA damage and apoptosis are associated with poly (ADP ribose) polymerase 1 inhibition in the rat testis. Eur J Pharmacol. 2014;737:29–40.PubMedGoogle Scholar
  5. 5.
    Kobayashi CI, Suda T. Regulation of reactive oxygen species in stem cells and cancer stem cells. J Cell Physiol. 2012;227:421–30.PubMedGoogle Scholar
  6. 6.
    de Lamirande E, Tsai C, Harakat A, Gagnon C. Involvement of reactive oxygen species in human sperm arcosome reaction induced by A23187, lysophosphatidylcholine, and biological fluid ultrafiltrates. J Androl. 1998;19:585–94.PubMedGoogle Scholar
  7. 7.
    Aitken RJ, Ryan AL, Baker MA, McLaughlin EA. Redox activity associated with the maturation and capacitation of mammalian spermatozoa. Free Radic Biol Med. 2004;36:994–1010.PubMedGoogle Scholar
  8. 8.
    Allamaneni SS, Naughton CK, Sharma RK, Thomas AJ Jr, Agarwal A. Increased seminal reactive oxygen species levels in patients with varicoceles correlate with varicocele grade but not with testis size. Fertil Steril. 2004;82:1684–6.PubMedGoogle Scholar
  9. 9.
    Benchaib M, Lornage J, Mazoyer C, Lejeune H, Salle B, Guerin JF. Sperm deoxyribonucleic acid fragmentation as a prognostic indicator of assisted reproductive technology outcome. Fertil Steril. 2007;87:93–100.PubMedGoogle Scholar
  10. 10.
    Collins JA, Barnhart KT, Schlegel PN. Do sperm DNA integrity tests predict pregnancy with in vitro fertilization? Fertil Steril. 2008;89:823–31.PubMedGoogle Scholar
  11. 11.
    Donnelly ET, McClure N, Lewis SE. Antioxidant supplementation in vitro does not improve human sperm motility. Fertil Steril. 1999;72:484–95.PubMedGoogle Scholar
  12. 12.
    Saleh RA, Agarwal A, Kandirali E, Sharma RK, Thomas AJ Jr, Nada EA, et al. Leukocytospermia is associated with increased reactive oxygen species production by human spermatozoa. Fertil Steril. 2002;78:1215–24.PubMedGoogle Scholar
  13. 13.
    Agarwal A, Hamamah S, Shekarriz M. Reactive oxygen species and fertilizing capacity of spermatozoa. Contracept Fertil Sex. 1994;22:327–30.Google Scholar
  14. 14.
    Kobayashi H, Gil-Guzman E, Mahran AM, Sharma RK, Nelson DR, Agarwal A. Quality control of reactive oxygen species measurement by luminol-dependent chemiluminescence assay. J Androl. 2001;22:568–74.PubMedGoogle Scholar
  15. 15.
    Zalata AA, Ahmed AH, Allamaneni S, Comhaire FH, Agarwal A. Relationship between acrosin activity of human spermatozoa and oxidative stress. Asian J Androl. 2004;6:313–8.PubMedGoogle Scholar
  16. 16.
    Hud NV, Downing KH, Balhorn R. A constant radius of curvature model for the organization of DNA in toroidal condensates. Proc Natl Acad Sci. 1995;92:3581–5.PubMedGoogle Scholar
  17. 17.
    Adenot PG, Mercier Y, Renard J-P, Thompson EM. Differential H4 acetylation of paternal and maternal chromatin precedes DNA replication and differential transcriptional activity in pronuclei of 1-cell mouse embryos. Development. 1997;124:4615–25.PubMedGoogle Scholar
  18. 18.
    Pittoggi C, Renzi L, Zaccagnini G, Cimini D, Degrassi F, Giordano R, et al. A fraction of mouse sperm chromatin is organized in nucleosomal hypersensitive domains enriched in retroposon DNA. J Cell Sci. 1999;112:3537–48.PubMedGoogle Scholar
  19. 19.
    Gineitis AA, Zalenskaya IA, Yau PM, Bradbury EM, Zalensky AO. Human sperm telomere–binding complex involves histone H2B and secures telomere membrane attachment. J Cell Biol. 2000;151:1591–8.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Churikov D, Siino J, Svetlova M, Zhang K, Gineitis A, Bradbury EM, et al. Novel human testis-specific histone H2B encoded by the interrupted gene on the X chromosome. Genomics. 2004;84:745–56.PubMedGoogle Scholar
  21. 21.
    Hammoud SS, Nix DA, Zhang H, Purwar J, Carrell DT, Cairns BR. Distinctive chromatin in human sperm packages genes for embryo development. Nature. 2009;460:473–8.PubMedPubMedCentralGoogle Scholar
  22. 22.
    Nadel B, de Lara J, Finkernagel SW, Steven Ward W. Cell-specific organization of the 5S ribosomal RNA gene cluster DNA loop domains in spermatozoa and somatic cells. Biol Reprod. 1995;53:1222–8.PubMedGoogle Scholar
  23. 23.
    Martins RP, Ostermeier GC, Krawetz SA. Nuclear matrix interactions at the human protamine domain a working model of potentiation. J Biol Chem. 2004;279:51862–8.PubMedGoogle Scholar
  24. 24.
    Bench G, Friz A, Corzett M, Morse D, Balhorn R. DNA and total protamine masses in individual sperm from fertile mammalian subjects. Cytometry. 1996;23:263–71.PubMedGoogle Scholar
  25. 25.
    Steger K. Transcriptional and translational regulation of gene expression in haploid spermatids. Anat Embryol. 1999;199:471–87.PubMedGoogle Scholar
  26. 26.
    Perreault SD, Zirkin BR. Sperm nuclear decondensation in mammals: role of sperm-associated proteinase in vivo. J Exp Zool. 1982;224:253–7.PubMedGoogle Scholar
  27. 27.
    Ohsumi K, Katagiri C, Yanagimachi R. Human sperm nuclei can transform into condensed chromosomes in Xenopus egg extracts. Gamete Res. 1988;20:1–9.PubMedGoogle Scholar
  28. 28.
    Balhorn R, Corzett M, Mazrimas J, Watkins B. Identification of bull protamine disulfides. Biochemistry. 1991;30:175–81.PubMedGoogle Scholar
  29. 29.
    Carrell DT, Emery BR, Hammoud S. Altered protamine expression and diminished spermatogenesis: what is the link? Hum Reprod Update. 2007;13:313–27.PubMedGoogle Scholar
  30. 30.
    Rathke C, Baarends WM, Jayaramaiah-Raja S, Bartkuhn M, Renkawitz R, Renkawitz-Pohl R. Transition from a nucleosome-based to a protamine-based chromatin configuration during spermiogenesis in Drosophila. J Cell Sci. 2007;120:1689–700.PubMedGoogle Scholar
  31. 31.
    Kuretake S, Kimura Y, Hoshi K, Yanagimachi R. Fertilization and development of mouse oocytes injected with isolated sperm heads. Biol Reprod. 1996;55:789–95.PubMedGoogle Scholar
  32. 32.
    Sexton WJ, Jarow JP. Effect of diabetes mellitus upon male reproductive function. Urology. 1997;49:508–13.PubMedGoogle Scholar
  33. 33.
    Delfino M, Imbrogno N, Elia J, Capogreco F, Mazzilli F. Prevalence of diabetes mellitus in male partners of infertile couples. Minerva Urologica e Nefrologica= The Italian Journal of Urology and Nephrology. 2007;59:131–5.PubMedGoogle Scholar
  34. 34.
    Kangralkar V, Patil SD, Bandivadekar R. Oxidative stress and diabetes: a review. Int J Pharm Appl. 2010;1:38–45.Google Scholar
  35. 35.
    Wautier J-L, Schmidt AM. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res. 2004;95:233–8.PubMedGoogle Scholar
  36. 36.
    Mallidis C, Agbaje I, Rogers D, Glenn J, McCullough S, Atkinson AB, et al. Distribution of the receptor for advanced glycation end products in the human male reproductive tract: prevalence in men with diabetes mellitus. Hum Reprod. 2007;22:2169–77.PubMedGoogle Scholar
  37. 37.
    Mallidis C, Agbaje I, Rogers D, Glenn J, Pringle R, Atkinson A, et al. Advanced glycation end products accumulate in the reproductive tract of men with diabetes. Int J Androl. 2009;32:295–305.PubMedGoogle Scholar
  38. 38.
    Laleethambika N, Dharwadkar MN, Santhy K, Sangeetha M, Silambuchelvi D, Balachandar V. Evaluation of M2/ANXA5 haplotype and P53 codon 72 polymorphism in a patient with recurrent pregnancy loss, ectopic pregnancy and recurrent implantation failure. Int J Hum Genet. 2016;16:166–71.Google Scholar
  39. 39.
    Tavares RS, Mansell S, Barratt CL, Wilson SM, Publicover SJ, Ramalho-Santos J. p, p′-DDE activates CatSper and compromises human sperm function at environmentally relevant concentrations. Hum Reprod. 2013;28:3167–77.PubMedPubMedCentralGoogle Scholar
  40. 40.
    Tavares RS, Amaral S, Paiva C, Baptista M, Ramalho-Santos J. In vitro exposure to the organochlorine p, p′-DDE affects functional human sperm parameters. Chemosphere. 2015;120:443–6.PubMedGoogle Scholar
  41. 41.
    Sousa MI, Amaral S, Tavares RS, Paiva C, Ramalho-Santos J. Concentration-dependent Sildenafil citrate (Viagra) effects on ROS production, energy status, and human sperm function. Syst Biol Reprod Med. 2014;60:72–9.PubMedGoogle Scholar
  42. 42.
    Scheepers A, Joost H-G, Schurmann A. The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. J Parenter Enter Nutr. 2004;28:364–71.Google Scholar
  43. 43.
    Bucci D, Rodriguez-Gil JE, Vallorani C, Spinaci M, Galeati G, Tamanini C. GLUTs and mammalian sperm metabolism. J Androl. 2011;32:348–55.PubMedGoogle Scholar
  44. 44.
    Joost H-G, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members. Mol Membr Biol. 2001;18:247–56.PubMedGoogle Scholar
  45. 45.
    Yang J, Cummings EA, O’connell C, Jangaard K. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol. 2006;108:644–50.PubMedGoogle Scholar
  46. 46.
    Purcell SH, Moley KH. Glucose transporters in gametes and preimplantation embryos. Trends Endocrinol Metab. 2009;20:483–9.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Dias TR, Alves MG, Silva BM, Oliveira PF. Sperm glucose transport and metabolism in diabetic individuals. Mol Cell Endocrinol. 2014;396:37–45.PubMedGoogle Scholar
  48. 48.
    Kawahito S, Kitahata H, Oshita S. Problems associated with glucose toxicity: role of hyperglycemia-induced oxidative stress. World J Gastroenterol: WJG. 2009;15:4137–42.PubMedGoogle Scholar
  49. 49.
    Ayepola OR, Brooks NL, Oguntibeju OO. Oxidative stress and diabetic complications: the role of antioxidant vitamins and flavonoids. Antioxidant-antidiabetic agents and human health. InTech; 2014.Google Scholar
  50. 50.
    Gomez E, Buckingham DW, Brindle J, Lanzafame F, Irvine DS, Aitken RJ. Development of an image analysis system to monitor the retention of residual cytoplasm by human spermatozoa: correlation with biochemical markers of the cytoplasmic space, oxidative stress, and sperm function. J Androl. 1996;17:276–87.PubMedGoogle Scholar
  51. 51.
    Alves M, Martins A, Rato L, Moreira P, Socorro S, Oliveira P. Molecular mechanisms beyond glucose transport in diabetes-related male infertility. Biochim Biophys Acta (BBA) – Mol Basis Dis. 2013;1832:626–35.Google Scholar
  52. 52.
    Muratori M, Tamburrino L, Marchiani S, Cambi M, Olivito B, Azzari C, et al. Investigation on the origin of sperm DNA fragmentation: role of apoptosis, immaturity and oxidative stress. Mol Med. 2015;21:109.PubMedPubMedCentralGoogle Scholar
  53. 53.
    Zhang C, Liu J, Pan H, Yang X, Bian K. Mitochondrial dysfunction induced by excessive ROS/RNS-metabolic cardiovascular disease and traditional Chinese medicines intervention. Zhongguo Zhong Yao za Zhi= Zhongguo Zhongyao zazhi= China Journal of Chinese Materia Medica. 2011;36:2423–8.PubMedGoogle Scholar
  54. 54.
    Jutte NH, Grootegoed J, Rommerts F, Van der Molen H. Exogenous lactate is essential for metabolic activities in isolated rat spermatocytes and spermatids. J Reprod Fertil. 1981;62:399–405.PubMedGoogle Scholar
  55. 55.
    Alves MG, Martins AD, Moreira PI, Carvalho RA, Sousa M, Barros A, et al. Metabolic fingerprints in testicular biopsies from type 1 diabetic patients. Cell Tissue Res. 2015;362:431–40.PubMedGoogle Scholar
  56. 56.
    Rato L, Alves M, Dias T, Cavaco J, Oliveira PF. Testicular metabolic reprogramming in neonatal streptozotocin-induced type 2 diabetic rats impairs glycolytic flux and promotes glycogen synthesis. J Diabetes Res. 2015;2015:1–13.Google Scholar
  57. 57.
    Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci. 2008;4:89.PubMedPubMedCentralGoogle Scholar
  58. 58.
    Lipinski B. Pathophysiology of oxidative stress in diabetes mellitus. J Diabetes Complicat. 2001;15:203–10.PubMedGoogle Scholar
  59. 59.
    Ceriello A. New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care. 2003;26:1589–96.PubMedGoogle Scholar
  60. 60.
    Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107:1058–70.PubMedPubMedCentralGoogle Scholar
  61. 61.
    Moussa S. Oxidative stress in diabetes mellitus. Romanian J Biophys. 2008;18:225–36.Google Scholar
  62. 62.
    SIKKA SC, Rajasekaran M, Hellstrom WJ. Role of oxidative stress and antioxidants in male infertility. J Androl. 1995;16:464–8.PubMedGoogle Scholar
  63. 63.
    Sharma RK, Agarwal A. Role of reactive oxygen species in male infertility. Urology. 1996;48:835–50.PubMedGoogle Scholar
  64. 64.
    Agarwal A, Hamada A, Esteves SC. Insight into oxidative stress in varicocele-associated male infertility: part 1. Nat Rev Urol. 2012;9:678–90.PubMedGoogle Scholar
  65. 65.
    Bansal AK, Bilaspuri G. Impacts of oxidative stress and antioxidants on semen functions. Vet Med Int. 2011;2011:1–7.Google Scholar
  66. 66.
    Saalu L. The incriminating role of reactive oxygen species in idiopathic male infertility: an evidence based evaluation. Pak J Biol Sci. 2010;13:413–22.PubMedGoogle Scholar
  67. 67.
    Hampl R, Drábková P, Kanďár R, Stěpán J. Impact of oxidative stress on male infertility. Ceska Gynekologie. 2012;77:241–5.PubMedGoogle Scholar
  68. 68.
    Ďuračková Z. Free radicals and antioxidants for non-experts. Systems biology of free radicals and antioxidants. Berlin: Springer; 2014. p. 3–38.Google Scholar
  69. 69.
    Wallach EE, Wolff H. The biologic significance of white blood cells in semen. Fertil Steril. 1995;63:1143–57.Google Scholar
  70. 70.
    Whittington K. Relative contribution of leukocytes and of spermatozoa to reactive oxygen species production in human sperm suspensions. Int J Androl. 1999;22:229–35.PubMedGoogle Scholar
  71. 71.
    Saleh RA, Agarwal A. Oxidative stress and male infertility: from research bench to clinical practice. J Androl. 2002;23:737–52.PubMedGoogle Scholar
  72. 72.
    Potts J, Pasqualotto F. Seminal oxidative stress in patients with chronic prostatitis. Andrologia. 2003;35:304–8.PubMedGoogle Scholar
  73. 73.
    Agarwal A, Tvrda E, Sharma R. Relationship amongst teratozoospermia, seminal oxidative stress and male infertility. Reprod Biol Endocrinol. 2014;12:45.PubMedPubMedCentralGoogle Scholar
  74. 74.
    Aitken RJ, Clarkson JS. Cellular basis of defective sperm function and its association with the genesis of reactive oxygen species by human spermatozoa. J Reprod Fertil. 1987;81:459–69.PubMedGoogle Scholar
  75. 75.
    John Aitken R, Clarkson JS, Fishel S. Generation of reactive oxygen species, lipid peroxidation, and human sperm function. Biol Reprod. 1989;41:183–97.Google Scholar
  76. 76.
    Hipler U, Görnig M, Hipler B, Römer W, Schreiber G. Stimulation and scavestrogen-induced inhibition of reactive oxygen species generated by rat sertoli cells. Arch Androl. 2000;44:147–54.PubMedGoogle Scholar
  77. 77.
    Shiraishi K, Matsuyama H, Takihara H. Pathophysiology of varicocele in male infertility in the era of assisted reproductive technology. Int J Urol. 2012;19:538–50.PubMedGoogle Scholar
  78. 78.
    Ko EY, Sabanegh ES Jr, Agarwal A. Male infertility testing: reactive oxygen species and antioxidant capacity. Fertil Steril. 2014;102:1518–27.PubMedGoogle Scholar
  79. 79.
    Lavranos G, Balla M, Tzortzopoulou A, Syriou V, Angelopoulou R. Investigating ROS sources in male infertility: a common end for numerous pathways. Reprod Toxicol. 2012;34:298–307.PubMedGoogle Scholar
  80. 80.
    Manda K, Ueno M, Moritake T, Anzai K. α-Lipoic acid attenuates x-irradiation-induced oxidative stress in mice. Cell Biol Toxicol. 2007;23:129–37.PubMedGoogle Scholar
  81. 81.
    Agarwal A, Deepinder F, Sharma RK, Ranga G, Li J. Effect of cell phone usage on semen analysis in men attending infertility clinic: an observational study. Fertil Steril. 2008;89:124–8.PubMedGoogle Scholar
  82. 82.
    Lao XQ, Zhang Z, Lau AK, Chan T-C, Chuang YC, Chan J, et al. Exposure to ambient fine particulate matter and semen quality in Taiwan. Occup Environ Med. 2018;75:148–54.PubMedGoogle Scholar
  83. 83.
    Younglai EV, Holloway AC, Foster WG. Environmental and occupational factors affecting fertility and IVF success. Hum Reprod Update. 2005;11:43–57.PubMedGoogle Scholar
  84. 84.
    Balachandar V, Kumar R, Prakash V, Devi SM, Kumar BL, Manikantan P, et al. Evaluation of genetic alterations in inhabitants of a naturally high level background radiation and Kudankulam nuclear power project site in India. Asian Pac J Cancer Prev. 2011;12:35–41.PubMedGoogle Scholar
  85. 85.
    Vellingiri B, Shanmugam S, Subramaniam MD, Balasubramanian B, Meyyazhagan A, Alagamuthu K, et al. Cytogenetic endpoints and xenobiotic gene polymorphism in lymphocytes of hospital workers chronically exposed to ionizing radiation in cardiology, radiology and orthopedic laboratories. Ecotoxicol Environ Saf. 2014;100:266–74.PubMedGoogle Scholar
  86. 86.
    Zini A, Kamal K, Phang D, Willis J, Jarvi K. Biologic variability of sperm DNA denaturation in infertile men. Urology. 2001;58:258–61.PubMedGoogle Scholar
  87. 87.
    Barroso G, Morshedi M, Oehninger S. Analysis of DNA fragmentation, plasma membrane translocation of phosphatidylserine and oxidative stress in human spermatozoa. Hum Reprod. 2000;15:1338–44.PubMedGoogle Scholar
  88. 88.
    Lopes S, Sun J-G, Jurisicova A, Meriano J, Casper RF. Sperm deoxyribonucleic acid fragmentation is increased in poor-quality semen samples and correlates with failed fertilization in intracytoplasmic sperm injection 1. Fertil Steril. 1998;69:528–32.PubMedGoogle Scholar
  89. 89.
    Irvine DS, Twigg JP, Gordon EL, Fulton N, Milne PA, Aitken RJ. DNA integrity in human spermatozoa: relationships with semen quality. J Androl. 2000;21:33–44.PubMedGoogle Scholar
  90. 90.
    Muratori M, Piomboni P, Baldi E, Filimberti E, Pecchioli P, Moretti E, et al. Functional and ultrastructural features of DNA-fragmented human sperm. J Androl. 2000;21:903–12.PubMedGoogle Scholar
  91. 91.
    Zini A, Bielecki R, Phang D, Zenzes MT. Correlations between two markers of sperm DNA integrity, DNA denaturation and DNA fragmentation, in fertile and infertile men. Fertil Steril. 2001;75:674–7.PubMedGoogle Scholar
  92. 92.
    De Lamirande E. The dark and bright sides of reactive oxygen species on sperm function. The male gamete: from basic science to clinical application. 1999;455–67.Google Scholar
  93. 93.
    Schulte RT, Ohl DA, Sigman M, Smith GD. Sperm DNA damage in male infertility: etiologies, assays, and outcomes. J Assist Reprod Genet. 2010;27:3–12.PubMedGoogle Scholar
  94. 94.
    McPherson S, Longo F. Chromatin structure-function alterations during mammalian spermatogenesis: DNA nicking and repair in elongating spermatids. 1993.Google Scholar
  95. 95.
    Marcon L, Boissonneault G. Transient DNA strand breaks during mouse and human spermiogenesis: new insights in stage specificity and link to chromatin remodeling. Biol Reprod. 2004;70:910–8.PubMedGoogle Scholar
  96. 96.
    Laberge R-M, Boissonneault G. On the nature and origin of DNA strand breaks in elongating spermatids. Biol Reprod. 2005;73:289–96.PubMedGoogle Scholar
  97. 97.
    Muratori M, Marchiani S, Maggi M, Forti G, Baldi E. Origin and biological significance of DNA fragmentation in human spermatozoa. Front Biosci. 2006;11:1491–9.PubMedGoogle Scholar
  98. 98.
    Twigg J, Irvine DS, Houston P, Fulton N, Michael L, Aitken RJ. Iatrogenic DNA damage induced in human spermatozoa during sperm preparation: protective significance of seminal plasma. Mol Hum Reprod. 1998;4:439–45.PubMedGoogle Scholar
  99. 99.
    Chen S, Allam J-P, Duan Y, Haidl G. Influence of reactive oxygen species on human sperm functions and fertilizing capacity including therapeutical approaches. Arch Gynecol Obstet. 2013;288:191–9.PubMedGoogle Scholar
  100. 100.
    Agarwal A, Saleh RA, Bedaiwy MA. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril. 2003;79:829–43.PubMedGoogle Scholar
  101. 101.
    Aitken RJ, Koppers AJ. Apoptosis and DNA damage in human spermatozoa. Asian J Androl. 2011;13:36–42.PubMedGoogle Scholar
  102. 102.
    Gharagozloo P, Aitken RJ. The role of sperm oxidative stress in male infertility and the significance of oral antioxidant therapy. Hum Reprod. 2011;26:1628–40.PubMedGoogle Scholar
  103. 103.
    Lewis SE, Simon L. Clinical implications of sperm DNA damage. Hum Fertil. 2010;13:201–7.Google Scholar
  104. 104.
    Zini A, San Gabriel M, Libman J. Lycopene supplementation in vitro can protect human sperm deoxyribonucleic acid from oxidative damage. Fertil Steril. 2010;94:1033–6.PubMedGoogle Scholar
  105. 105.
    Hikim AS, Swerdloff RS. Hormonal and genetic control of germ cell apoptosis in the testis. Rev Reprod. 1999;4:38–47.Google Scholar
  106. 106.
    Rodriguez I, Ody C, Araki K, Garcia I, Vassalli P. An early and massive wave of germinal cell apoptosis is required for the development of functional spermatogenesis. EMBO J. 1997;16:2262–70.PubMedPubMedCentralGoogle Scholar
  107. 107.
    Comar VA, Petersen CG, Mauri AL, Mattila M, Vagnini LD, Renzi A, et al. Influence of the abstinence period on human sperm quality: analysis of 2,458 semen samples. JBRA Assist Reprod. 2017;21:306.PubMedPubMedCentralGoogle Scholar
  108. 108.
    Long L, Qiu H, Cai B, Chen N, Lu X, Zheng S, et al. Hyperglycemia induced testicular damage in type 2 diabetes mellitus rats exhibiting microcirculation impairments associated with vascular endothelial growth factor decreased via PI3K/Akt pathway. Oncotarget. 2018;9:5321.PubMedPubMedCentralGoogle Scholar
  109. 109.
    DeVries A, Vercelli D. Epigenetic mechanisms in asthma. Ann Am Thorac Soc. 2016;13:S48–50.PubMedPubMedCentralGoogle Scholar
  110. 110.
    Griseri P, Garrone O, Sardo AL, Monteverde M, Rusmini M, Tonissi F, et al. Genetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients. Oncotarget. 2016;7:26465.PubMedPubMedCentralGoogle Scholar
  111. 111.
    Kim SY, Morales C, Gillette TG, Hill JA. Epigenetic regulation in heart failure. Curr Opin Cardiol. 2016;31:255–65.PubMedPubMedCentralGoogle Scholar
  112. 112.
    Guerrero-Bosagna C, Skinner MK. Environmentally induced epigenetic transgenerational inheritance of male infertility. Curr Opin Genet Dev. 2014;26:79–88.PubMedGoogle Scholar
  113. 113.
    Komiya A, Kawauchi Y, Kato T, Watanabe A, Tanii I, Fuse H. Sperm nuclear vacuoles in relation to acrosome reactions and sperm motility. Sci World J. 2014;2014:1–8.Google Scholar
  114. 114.
    Oldereid NB, Hanevik HI, Bakkevig I, Romundstad LB, Magnus Ø, Hazekamp J, et al. Pregnancy outcome according to male diagnosis after ICSI with non-ejaculated sperm compared with ejaculated sperm controls. Reprod BioMed Online. 2014;29:417–23.PubMedGoogle Scholar
  115. 115.
    Wosnitzer M, Goldstein M, Hardy MP. Review of azoospermia. Spermatogenesis. 2014;4:e28218.PubMedPubMedCentralGoogle Scholar
  116. 116.
    Xu A-M, Liu B-J, Wang Z-J. DAZL and male infertility: an update. Zhonghua nan ke xue= National Journal of Andrology. 2014;20:647–50.PubMedGoogle Scholar
  117. 117.
    Marques CJ, Francisco T, Sousa S, Carvalho F, Barros A, Sousa M. Methylation defects of imprinted genes in human testicular spermatozoa. Fertil Steril. 2010;94:585–94.PubMedGoogle Scholar
  118. 118.
    Paoloni-Giacobino A. Epigenetics in reproductive medicine. Pediatr Res. 2007;61:51R–7R.PubMedGoogle Scholar
  119. 119.
    Kuramochi-Miyagawa S, Watanabe T, Gotoh K, Totoki Y, Toyoda A, Ikawa M, et al. DNA methylation of retrotransposon genes is regulated by Piwi family members MILI and MIWI2 in murine fetal testes. Genes Dev. 2008;22:908–17.PubMedPubMedCentralGoogle Scholar
  120. 120.
    Omisanjo OA, Biermann K, Hartmann S, Heukamp LC, Sonnack V, Hild A, et al. DNMT1 and HDAC1 gene expression in impaired spermatogenesis and testicular cancer. Histochem Cell Biol. 2007;127:175–81.PubMedGoogle Scholar
  121. 121.
    De Lamirande E, Leclerc P, Gagnon C. Capacitation as a regulatory event that primes spermatozoa for the acrosome reaction and fertilization. Mol Hum Reprod. 1997;3:175–94.PubMedGoogle Scholar
  122. 122.
    Marques CJ, João Pinho M, Carvalho F, Bièche I, Barros A, Sousa M. DNA methylation imprinting marks and DNA methyltransferase expression in human spermatogenic cell stages. Epigenetics. 2011;6:1354–61.PubMedGoogle Scholar
  123. 123.
    Dada R, Kumar M, Jesudasan R, Fernández JL, Gosálvez J, Agarwal A. Epigenetics and its role in male infertility. J Assist Reprod Genet. 2012;29:213–23.PubMedPubMedCentralGoogle Scholar
  124. 124.
    Bhattacharyya T, Gregorova S, Mihola O, Anger M, Sebestova J, Denny P, et al. Mechanistic basis of infertility of mouse intersubspecific hybrids. Proc Natl Acad Sci. 2013;110:E468–77.PubMedGoogle Scholar
  125. 125.
    Gabory A, Attig L, Junien C. Epigenetic mechanisms involved in developmental nutritional programming. World J Diabetes. 2011;2:164–75.PubMedPubMedCentralGoogle Scholar
  126. 126.
    Cortessis VK, Thomas DC, Levine AJ, Breton CV, Mack TM, Siegmund KD, et al. Environmental epigenetics: prospects for studying epigenetic mediation of exposure–response relationships. Hum Genet. 2012;131:1565–89.PubMedPubMedCentralGoogle Scholar
  127. 127.
    Berthaut I, Montjean D, Dessolle L, Morcel K, Deluen F, Poirot C, et al. Effect of temozolomide on male gametes: an epigenetic risk to the offspring? J Assist Reprod Genet. 2013;30:827–33.PubMedPubMedCentralGoogle Scholar
  128. 128.
    Soubry A, Hoyo C, Jirtle RL, Murphy SK. A paternal environmental legacy: evidence for epigenetic inheritance through the male germ line. BioEssays. 2014;36:359–71.PubMedPubMedCentralGoogle Scholar
  129. 129.
    Feuer S, Camarano L, Rinaudo P. ART and health: clinical outcomes and insights on molecular mechanisms from rodent studies. Mol Hum Reprod. 2012;19:189–204.PubMedPubMedCentralGoogle Scholar
  130. 130.
    Webster KE, O’Bryan MK, Fletcher S, Crewther PE, Aapola U, Craig J, et al. Meiotic and epigenetic defects in Dnmt3L-knockout mouse spermatogenesis. Proc Natl Acad Sci. 2005;102:4068–73.PubMedGoogle Scholar
  131. 131.
    Jelodar G, Khaksar Z, Pourahmadi M. Endocrine profile and testicular histomorphometry in adult rat offspring of diabetic mothers. J Physiol Sci. 2009;59:377–82.PubMedGoogle Scholar
  132. 132.
    Hata K, Kusumi M, Yokomine T, Li E, Sasaki H. Meiotic and epigenetic aberrations in Dnmt3L-deficient male germ cells. Mol Reprod Dev. 2006;73:116–22.PubMedGoogle Scholar
  133. 133.
    Kato Y, Kaneda M, Hata K, Kumaki K, Hisano M, Kohara Y, et al. Role of the Dnmt3 family in de novo methylation of imprinted and repetitive sequences during male germ cell development in the mouse. Hum Mol Genet. 2007;16:2272–80.PubMedGoogle Scholar
  134. 134.
    Tsounapi P, Honda M, Dimitriadis F, Kawamoto B, Hikita K, Muraoka K, et al. Impact of antioxidants on seminal vesicles function and fertilizing potential in diabetic rats. Asian J Androl. 2017;19:639.PubMedGoogle Scholar
  135. 135.
    Wroblewski N, Schill W-B, Henkel R. Metal chelators change the human sperm motility pattern. Fertil Steril. 2003;79:1584–9.PubMedGoogle Scholar
  136. 136.
    Agarwal A, Nallella KP, Allamaneni SS, Said TM. Role of antioxidants in treatment of male infertility: an overview of the literature. Reprod BioMed Online. 2004;8:616–27.PubMedGoogle Scholar
  137. 137.
    Lenzi A, Sgro P, Salacone P, Paoli D, Gilio B, Lombardo F, et al. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril. 2004;81:1578–84.PubMedGoogle Scholar
  138. 138.
    Wei Y, Yang C-R, Wei Y-P, Zhao Z-A, Hou Y, Schatten H, et al. Paternally induced transgenerational inheritance of susceptibility to diabetes in mammals. Proc Natl Acad Sci. 2014;111:1873–8.PubMedGoogle Scholar
  139. 139.
    Biemond P, Van Eijk H, Swaak A, Koster JF. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases. J Clin Invest. 1984;73:1576–9.PubMedPubMedCentralGoogle Scholar
  140. 140.
    Ochsendorf F. Infections in the male genital tract and reactive oxygen species. Hum Reprod Update. 1999;5:399–420.PubMedGoogle Scholar
  141. 141.
    Greco E, Iacobelli M, Rienzi L, Ubaldi F, Ferrero S, Tesarik J. Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment. J Androl. 2005;26:349–53.PubMedGoogle Scholar
  142. 142.
    Bahmanzadeh M, Vahidinia A, Mehdinejadiani S, Shokri S, Alizadeh Z. Dietary supplementation with astaxanthin may ameliorate sperm parameters and DNA integrity in streptozotocin-induced diabetic rats. Clin Exp Reprod Med. 2016;43:90–6.PubMedPubMedCentralGoogle Scholar
  143. 143.
    Fontoura P, Mello MD, Gallo-Sá P, Erthal-Martins MC, Cardoso MCA, Ramos C. Leptin improves sperm cryopreservation via antioxidant defense. J Reprod Infertil. 2017;18:172.PubMedPubMedCentralGoogle Scholar
  144. 144.
    Dawson EB, Harris WA, Rankin WE, Charpentier LA, McGANITY WJ. Effect of ascorbic acid on male fertility. Ann N Y Acad Sci. 1987;498:312–23.PubMedGoogle Scholar
  145. 145.
    Showell MG, Mackenzie-Proctor R, Brown J, Yazdani A, Stankiewicz MT, Hart RJ. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2014.Google Scholar
  146. 146.
    Ding S-S, Sun P, Zhang Z, Liu X, Tian H, Huo Y-W, et al. Moderate dose of Trolox preventing the deleterious effects of Wi-fi radiation on spermatozoa in vitro through reduction of oxidative stress damage. Chin Med J. 2018;131:402.PubMedPubMedCentralGoogle Scholar
  147. 147.
    Zhu Z, Ren Z, Fan X, Pan Y, Lv S, Pan C, et al. Cysteine protects rabbit spermatozoa against reactive oxygen species-induced damages. PLoS One. 2017;12:e0181110.PubMedPubMedCentralGoogle Scholar
  148. 148.
    Hisatomi A, Sakuma S, Fujiwara M, Seki J. Effect of tacrolimus on the cauda epididymis in rats: analysis of epididymal biochemical markers or antioxidant defense enzymes. Toxicology. 2008;243:23–30.PubMedGoogle Scholar
  149. 149.
    Cesar Mora-Esteves, David Shin, Nutrient Supplementation: Improving Male Fertility Fourfold. Seminars in Reproductive Medicine 2013;31(04):293–300Google Scholar
  150. 150.
    Baker HW, Brindle J, Irvine DS, Aitken RJ. Protective effect of antioxidants on the impairment of sperm motility by activated polymorphonuclear leukocytes. Fertil Steril. 1996;65(2):411–9.Google Scholar
  151. 151.
    de Lamirande E, Leclerc P, Gagnon C. Capacitation as a regulatory event that primes spermatozoa for the acrosome reaction and fertilization. Mol Hum Reprod. 1997;3(3):175–94.Google Scholar
  152. 152.
    Fanuel Lampiao, Free radicals generation in an fertilization setting and how to minimize them. World Journal of Obstetrics and Gynecology 2012;1(3):29.Google Scholar
  153. 153.
    Rakesh K. Sharma, Ashok Agarwal, Role of reactive oxygen species in male infertility. Urology 1996;48(6):835–850.Google Scholar
  154. 154.
    Helmut SIES, Strategies of antioxidant defense. European Journal of Biochemistry 1993;215(2):213–219.Google Scholar
  155. 155.
    Amrit Kaur Bansal, G. S. Bilaspuri, Impacts of Oxidative Stress and Antioxidants on Semen Functions. Veterinary Medicine International 2011:1–7.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  • Nagarajan Laleethambika
    • 1
  • Venugopal Anila
    • 1
  • Chandran Manojkumar
    • 1
    Email author
  • Ishvarya Muruganandam
    • 1
  • Bupesh Giridharan
    • 2
  • Thangarasu Ravimanickam
    • 3
  • Vellingiri Balachandar
    • 1
    Email author
  1. 1.Human Molecular Genetics and Stem Cell Laboratory, Department of Human Genetics and Molecular BiologyBharathiar UniversityCoimbatoreIndia
  2. 2.Cancer and Virology Laboratory, Sree Balaji Medical College and HospitalBharath UniversityChennaiIndia
  3. 3.Department of Zoology, School of ScienceTamil Nadu Open UniversityChennaiIndia

Personalised recommendations